Two-site study on performances of a commercially available MALDI-TOF MS-based assay for the detection of colistin resistance in Escherichia coli

Colistin is a last resort drug for the treatment of multiple drug-resistant (MDR) Gram-negative bacterial infections. Rapid methods to detect resistance are highly desirable. Here, we evaluated the performance of a commercially available MALDI-TOF MS-based assay for colistin resistance testing in Es...

Descripción completa

Detalles Bibliográficos
Autores principales: Larrouy-Maumus, Gerald, Dortet, Laurent, Nix, Ilka D., Maier, Thomas, Oberheitmann, Boris, Sparbier, Katrin, Kostrzewa, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172212/
https://www.ncbi.nlm.nih.gov/pubmed/36973378
http://dx.doi.org/10.1007/s10096-023-04587-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172212/
https://www.ncbi.nlm.nih.gov/pubmed/36973378
http://dx.doi.org/10.1007/s10096-023-04587-9

Ejemplares similares